Uždaryti

LT - LT


Please select a country and, if applicable, a language.

Straipsnio apžvalga

Stress symptoms: Evidence supporting a phytopharmaceutical product with new marketing authorisation…


Phytotherapeutics are used in many countries to treat stress symptoms such as mild sleep disorders, anxiety, increased irritability, tension and nervous restlessness. An established combination prepar ...

Į straipsnį
Autorius: Christiane Kolb, PhD ir Heba Aziz-Kalbhenn, PhDEFSM: 2022;2:220039DOI: 10.52778/efsm.22.0039Data: 27.02.2022

Study confirms the effect of a supplement on the micronutrient content of breast milk


Even in countries with a high standard of living, the intake of essential nutrients by breast-feeding women is often inadequate – with potentially negative effects on the development of their baby. A ...

Į straipsnį
Autorius: Jens SeibelEFSM: 2022;2:220037DOI: 10.52778/efsm.22.0037Data: 21.02.2022

Intranasal triamcinolone acetonide effectively improves nasal symptoms and quality of life in …


Allergic rhinitis is a common problem with increasing prevalence. Two recent publications demonstrate that intranasal triamcinolone acetonide is an effective treatment that progressively improves nasa ...

Į straipsnį
Autorius: Mohamed Amessou, PhD, Elizaveta Leshcheva, PharmD, Aleksandr Maslakov, MD, PhD ir Palak Venkataraman, PharmDEFSM: 2022;2:220022DOI: 10.52778/efsm.22.0022Data: 05.02.2022

Update on the antibiotic treatment of uncomplicated skin abscesses


Cutaneous abscesses are often caused by S. aureus. The most important therapeutic measure is drainage of the accumulated pus. Although the clinical benefit from additionally administering oral antibio ...

Į straipsnį
Autorius: Annette Sethmann, PhDEFSM: 2022;2:220035DOI: 10.52778/efsm.22.0035Data: 31.01.2022

Probiotics can prevent drug-induced gastrointestinal symptoms


Probiotics such as Bacillus clausii reduce the occurrence of gastrointestinal side effects of commonly used medications such as antibiotics and proton pump inhibitors in placebo-controlled randomized ...

Į straipsnį
Autorius: Manuel Plomer, PhD ir Marcos III Perez, MDEFSM: 2022;2:220009DOI: 10.52778/efsm.22.0009Data: 26.01.2022

The probiotic Bacillus clausii is an effective treatment of acute diarrhea in children


A systematic review and meta-analysis confirms that the probiotic Bacillus clausii is an effective treatment for acute diarrhea in childhood. It shortens the duration of diarrhea and associated hospit ...

Į straipsnį
Autorius: Marcos III Perez, MD ir Dorothea M. Greifenberg, PhDEFSM: 2022;2:220003DOI: 10.52778/efsm.22.0003Data: 21.01.2022

Better understanding of “21st century headache” via real-world data


Throughout the world, headache is one of the main causes of limitations in daily life and/or unfitness to work. 50% of sufferers never consult a doctor and instead turn to self-medication. A recently ...

Į straipsnį
Autorius: Luminita Constantin, MD, Marion Eberlin, PhD, Iva Igracki Turudic, MD ir Martin C. Michel, MDEFSM: 2022;2:220001DOI: 10.52778/efsm.22.0001Data: 17.01.2022

Bisacodyl: comprehensive findings direct effective and safe use in constipation


For the first time since bisacodyl was licensed in the 1950s, an up-to-date review has provided a thorough summary of the pharmacological and clinical data concerning this prokinetic and secretagogic ...

Į straipsnį
Autorius: Sabine Landes, PhD, Marion Eberlin, PhD ir Robert Lange, PhDEFSM: 2021;1:210338DOI: 10.52778/efsm.21.0338Data: 06.12.2021

Essential phospholipids in fatty liver diseases


The liver is an important organ of metabolism and the immune system. An oversupply of carbohydrates or excessive alcohol consumption can trigger inflammatory processes and lead to the development of f ...

Į straipsnį
Autorius: Assoc. Prof. Peter Minárik, MD, PhD, MSc ir Eva Koscova, MD, PhD, MBAEFSM: 2021;1:210346DOI: 10.52778/efsm.21.0346Data: 05.12.2021

Allergic Rhinitis and air pollution: New clinical evidence with fexofenadine hydrochloride 180 mg


Exposure to air pollutants and climate change are contributing factors of increasing prevalence and allergic rhinitis (AR) symptom exacerbation. Fexofenadine 180 mg has been shown effective in relievi ...

Į straipsnį
Autorius: Margarita Murrieta-Aguttes, MD ir Marina Volonte, DVMEFSM: 2021;1:210332DOI: 10.52778/efsm.21.0332Data: 29.11.2021